Bright Minds Biosciences company info

What does Bright Minds Biosciences do?
Bright Minds Biosciences (NASDAQ:DRUG) is a company focused on developing innovative therapies for patients suffering from neuropsychiatric disorders, epilepsy, and pain. With a commitment to improving the lives of those impacted by these challenging conditions, Bright Minds Biosciences leverages cutting-edge science to create more effective and safer treatment options. Through its research and development activities, the company aims to unlock new possibilities in medical treatment and contribute significantly to the field of mental health and neurological diseases. With its dedication to advancing healthcare, Bright Minds Biosciences is driven by the objective to usher in a new era of therapeutic solutions that can transform patient care and outcomes.
Bright Minds Biosciences company media
Company Snapshot

Is Bright Minds Biosciences a public or private company?

key
Ownership
Public

How many people does Bright Minds Biosciences employ?

people
Employees
23

What sector is Bright Minds Biosciences in?

pie chart
Sector
Health Care

Where is the head office for Bright Minds Biosciences?

location pin
Head Office
New York, United States

What year was Bright Minds Biosciences founded?

founded flag
Year Founded
2017
What does Bright Minds Biosciences specialise in?
/Psychedelic Medicines /Mental Health /Neurological Disorders /Drug Development /Intellectual Property /Biomolecular Research

What are the products and/or services of Bright Minds Biosciences?

Overview of Bright Minds Biosciences offerings
Development of next-generation serotonergic compounds to treat neuropsychiatric and neurological disorders.
Research on psychedelics for creating non-hallucinogenic mental health treatments.
Innovations in the field of epilepsy, focusing on novel treatment options.
Pioneering the use of 5-HT receptor modulators for brain health.
Advancement in therapies for pain management without the use of opioids.
Exploration of treatments for cognitive impairments and neurodegenerative diseases.

Who is in the executive team of Bright Minds Biosciences?

Bright Minds Biosciences leadership team
  • Mr. Ian  McDonald
    Mr. Ian McDonald
    Co-Founder, CEO, President & Director
  • Mr. Ryan E. S. K. Cheung B.Com., CA, CPA
    Mr. Ryan E. S. K. Cheung B.Com., CA, CPA
    Chief Financial Officer
  • Dr. Jan Torleif Pedersen M.Sc., Ph.D.
    Dr. Jan Torleif Pedersen M.Sc., Ph.D.
    Chief Science Officer & Director
  • Dr. Mark A. Smith M.D., Ph.D.
    Dr. Mark A. Smith M.D., Ph.D.
    Chief Medical Officer
  • Dr. Emer  Leahy M.B.A., Ph.D.
    Dr. Emer Leahy M.B.A., Ph.D.
    Consultant